Product Code: ANV1815
REPORT HIGHLIGHT
Heparin Market size was valued at USD 9,530 Million in 2022, expanding at a CAGR of 4.2 % from 2023 to 2030.
Heparin is a highly efficient anticoagulant employed in the medical field to prevent the formation of blood clots. This versatile substance can be derived from animal tissues or synthetically synthesized. Its mechanism of action involves the inhibition of critical blood clotting factors like thrombin and factor Xa, effectively reducing the risk of dangerous blood clot development. Heparin administration typically involves injections and plays a vital role in various therapeutic scenarios, such as surgical procedures, dialysis, and the management of conditions like deep vein thrombosis. What sets heparin apart is its rapid onset and the ability to reverse its effects, making it a crucial tool in the treatment of thrombotic disorders. Nevertheless, the precise dosage and monitoring are essential to prevent potential bleeding complications, underscoring its significance in modern medical practice.
Heparin Market- Market Dynamics
Heparin's efficacy in preventing and treating blood clots propel market demand
Heparin, a potent anticoagulant, serves as a rapid and indispensable agent in situations demanding immediate clot prevention or dissolution, including surgical procedures, cardiac interventions, and the management of ailments like deep vein thrombosis and pulmonary embolism. The widespread applicability of heparin, spanning both preventive and therapeutic purposes, enhances patient safety and elevates treatment outcomes in various medical scenarios. Its unique feature lies in its adaptability and the ability to swiftly adapt to changing conditions, ensuring patient well-being even in cases of potential bleeding complications.
Heparin Market- Key Insights
According to insights shared by our research analyst, the global Heparin market is poised to exhibit a steady annual growth rate of approximately 4.2% during the projected period from 2023 to 2030.
The market's momentum can be attributed to Heparin's well-established effectiveness in the prevention and treatment of blood clots, making it a pivotal component of medical practice.
In terms of segmentation, Unfractionated Heparin (UFH) emerged as the dominant category in 2022, reflecting its significant market share. Additionally, within the Source category, Porcine-derived Heparin held a leading position in 2022.
Regionally, Asia Pacific emerged as the primary contributor to market revenues in 2022. The diverse factors driving market growth in this region highlight its significance on the global stage.
Heparin Market- Segmentation Analysis:
The global Heparin Market exhibits a segmentation based on Type, Source, Application, and Region. Within this market landscape, we find two primary categories under the Type segment: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH).
Of these categories, Unfractionated Heparin (UFH) emerges as the dominant force in the market. UFH plays a vital role as an anticoagulant in various medical settings, including surgical procedures, cardiac interventions, and the management of thrombotic disorders. Its widespread use is attributed to its capacity to ensure patient safety by preventing or treating potentially dangerous blood clots.
Heparin Market- Geographical Insights
The global Heparin Market extends its influence across diverse regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Each of these regions is further subdivided into countries that actively engage in market activities.
The Asia-Pacific region stands out as a significant growth hub for Heparin, with escalating demand influenced by various factors. The region's aging demographic contributes to this demand surge. Moreover, an upsurge in cardiovascular diseases, deep vein thrombosis, and other clot-related conditions has fueled the need for Heparin in this region. These dynamics underline the growing significance of Heparin in addressing health concerns.
Heparin Market- Competitive Landscape:
The competitive landscape within the Heparin market is marked by the presence of several notable players who exert influence in the industry. Prominent pharmaceutical giants like Pfizer, Sanofi, and Fresenius Kabi occupy substantial market share due to their extensive range of products and global presence. These major players offer diverse Heparin formulations tailored to cater to the requirements of various medical applications. Additionally, the market sees participation from generic pharmaceutical manufacturers who strive to gain a competitive edge by presenting cost-effective alternatives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEPARIN MARKET KEY PLAYERS
- Pfizer
- Sanofi
- Fresenius Kabi
- Aspen Pharmacare
- LEO Pharma
- Teva Pharmaceuticals
- Amphastar Pharmaceuticals
- Baxter International
- GlaxoSmithKline (GSK)
- B. Braun Melsungen AG
- Mylan
- Sandoz
- Leo Pharma
- Pfizer
- Hikma Pharmaceuticals
GLOBAL HEPARIN MARKET, BY TYPE
- Unfractionated Heparin
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMWH)
GLOBAL HEPARIN MARKET, BY SOURCE
GLOBAL HEPARIN MARKET, BY APPLICATION
- Deep Vein Thrombosis (DVT)
- Atrial Fibrillation and Heart Attack
- Coronery Artery Disease
- Other Applications
GLOBAL HEPARIN MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Heparin Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Heparin Market Snippet by Type
- 2.1.2. Heparin Market Snippet by Source
- 2.1.3. Heparin Market Snippet by Application
- 2.1.4. Heparin Market Snippet by Country
- 2.1.5. Heparin Market Snippet by Region
- 2.2. Competitive Insights
3. Heparin Key Market Trends
- 3.1. Heparin Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Heparin Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Heparin Market Opportunities
- 3.4. Heparin Market Future Trends
4. Heparin Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Heparin Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Heparin Market Landscape
- 6.1. Heparin Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Heparin Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
- 7.1.2. Unfractionated Heparin
- 7.1.3. Low Molecular Weight Heparin (LMWH)
- 7.1.4. Ultra-low Molecular Weight Heparin (ULMWH)
8. Heparin Market - By Source
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
- 8.1.2. Bovine
- 8.1.3. Porcine
9. Heparin Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 9.1.2. Deep Vein Thrombosis (DVT)
- 9.1.3. Atrial Fibrillation and Heart Attack
- 9.1.4. Coronery Artery Disease
- 9.1.5. Other Applications
10. Heparin Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Heparin Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Heparin Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Heparin Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Heparin Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Heparin Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Heparin Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Pfizer
- 11.2.2. Sanofi
- 11.2.3. Fresenius Kabi
- 11.2.4. Aspen Pharmacare
- 11.2.5. LEO Pharma
- 11.2.6. Teva Pharmaceuticals
- 11.2.7. Amphastar Pharmaceuticals
- 11.2.8. Baxter International
- 11.2.9. GlaxoSmithKline (GSK)
- 11.2.10. B. Braun Melsungen AG
- 11.2.11. Mylan
- 11.2.12. Sandoz
- 11.2.13. Leo Pharma
- 11.2.14. Pfizer
- 11.2.15. Hikma Pharmaceuticals
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us